http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0228185-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
filingDate 1989-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74598274fbabde0ecf7e1fb21e132e35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d4d6450649e4a542556cfdd6d6123d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aabd2ed491739b77df1ce3b8b90eee7
publicationDate 1990-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0228185-A
titleOfInvention Cephalosporin compound and synthetic intermediate thereof
abstract NEW MATERIAL:A compound expressed by formula I [R 1 is H, (carboxy substituted) lower alkyl or oxopyrrolidyl; R 2 is phenyl having 1-3 substituent group such as OH; A is formula II or formula III, whose N-6 membered ring part is occasionally substituted by ≤2 carboxyl groups : B is bond hand, -CH 2 -, -CH 2 -CH 2 - or formula IV]. n EXAMPLE: 7β-[2-(2-Aminothiazol-yl)-2(Z)-(2-carboxypropyl-2-oxyimino) acetamide]-3-[1-(3,4-dihydroxyphenyl)-4-pyridinio]thiomethyl-3-cephem-4- carboxylate monosodium salt. n USE: An antimicrobial agent. n PREPARATION: A compound expressed by formula V [R 3 is (protected)amino; X 1 is reactive residue] is reacted with a thiopyrrolidone expressed by formula VI or thiopyridine expressed by formula VII. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019205843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9290515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5498393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2960244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3777979-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11440886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102203100-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9809605-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239890-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000509-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-019520-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009310959-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014065732-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110090982-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010050468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019258242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012147773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110407741-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9242999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9334289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014068388-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9145425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011125967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9862729-B2
priorityDate 1988-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416186226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2775267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 51.